Literature DB >> 2482177

Affinity electrophoresis for studies of mechanisms regulating glycosylation of plasma proteins.

A Mackiewicz1, I Kushner.   

Abstract

A model system for studies of mechanisms governing the alterations of glycosylation of plasma glycoproteins was developed. The system employs two human hepatoma cell lines, Hep 3B and Hep G2, as target cells and agarose affinity electrophoresis with lectins for studies of microheterogeneity of alpha 1-protease inhibitor (PI), a model glycoprotein synthesized by hepatocytes. As an example for the application of the system, the effect of cytokines on major microheterogeneity of plasma proteins is demonstrated. The results indicate that interleukin 6, transforming growth factor beta 1 and, to some extent, tumor necrosis factor alpha are directly involved in regulating the pattern of glycosylation of plasma proteins in vitro, but the major effect is obtained by using combinations of interleukin 6, transforming growth factor beta 1, tumor necrosis factor alpha and interleukin 1. In addition, the results underline the dissociation between alteration of gene expression and the changes in the pattern of plasma protein glycosylation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482177     DOI: 10.1002/elps.1150101206

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  4 in total

1.  Lectin affinity electrophoresis.

Authors:  R J Linhardt; X J Han; J R Fromm
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

2.  Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro.

Authors:  A Mackiewicz; M Sobieska; M Kapciñska; S H Mackiewicz; K E Wiktorowicz; T Pawłowski
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

3.  Still's disease in children and adults: a distinct pattern of acute-phase proteins.

Authors:  M Sobieska; K Fassbender; A Aeschlimann; P Bourgeois; S Mackiewicz; W Müller
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis.

Authors:  P Hrycaj; T Stratz; C Kovac; P Mennet; W Müller
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.